Night Blindness Treatment Market Report 2026
Download Free Sample Buy Now
Night Blindness Treatment Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Night Blindness Treatment Market Report 2026

Global Outlook – By Treatment (Medication, Surgery, Other Treatments), By Diagnosis (Blood Tests, Color Vision Testing, Pupil Light Reflex, Refraction, Retinal Exam, Electroretinogram (ERG), Other Diagnoses), By Symptom (Eye Pain, Cloudy Vision, Halos, Light Sensitivity, Distance Vision Problem, Other Symptoms), By End User (Clinic, Hospital, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Night Blindness Treatment Market Overview

• Night Blindness Treatment market size has reached to $4.2 billion in 2025

• Expected to grow to $5.66 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%

• Growth Driver: Impact Of Increasing Cataract Prevalence On The Night Blindness Treatment Market

• Market Trend: Innovative Genetic Therapies Revolutionizing Night Blindness Treatment Market

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Night Blindness Treatment Market?

Night blindness treatment refers to interventions aiming to alleviate conditions such as vitamin A deficiency and other issues impairing vision in low light settings. It aims to enhance visual acuity in dim conditions and improve overall visual function by addressing underlying causes. The purpose of night blindness treatment is to improve the patient's ability to see in low-light conditions and at night. This treatment aims to address the underlying causes of night blindness and alleviate the symptoms.

The main treatments in the night blindness treatment market are medication, surgery, and other treatments. Night blindness medication refers to treatments aimed at improving vision in low-light conditions, often targeting underlying conditions such as vitamin A deficiency, retinitis pigmentosa, or other retinal disorders. Night blindness can be diagnosed with blood tests, color vision testing, pupil light reflex, refraction, retinal exam, electroretinogram (ERG), and others. The symptoms include eye pain, vomiting, cloudy vision, halos, light sensitivity, distance vision problem, headache, and others. The end users are clinic, hospital, and others.

Night Blindness Treatment Market Global Report 2026 Market Report bar graph

What Is The Night Blindness Treatment Market Size and Share 2026?

The night blindness treatment market size has grown strongly in recent years. It will grow from $4.2 billion in 2025 to $4.46 billion in 2026 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to high prevalence of malnutrition, limited access to eye care services, growing awareness of vision disorders, increasing geriatric population, advancements in ophthalmic diagnostics.

What Is The Night Blindness Treatment Market Growth Forecast?

The night blindness treatment market size is expected to see strong growth in the next few years. It will grow to $5.66 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to rising investment in eye health programs, increasing demand for personalized treatments, expansion of gene therapy applications, growth in healthcare infrastructure, improving reimbursement policies. Major trends in the forecast period include rising prevalence of vitamin A deficiency, increasing adoption of early diagnosis techniques, growth in minimally invasive eye surgeries, expanding use of nutritional and preventive therapies, improved access to vision care in emerging economies.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Night Blindness Treatment Market Segmentation

1) By Treatment: Medication, Surgery, Other Treatments

2) By Diagnosis: Blood Tests, Color Vision Testing, Pupil Light Reflex, Refraction, Retinal Exam, Electroretinogram (ERG), Other Diagnoses

3) By Symptom: Eye Pain, Cloudy Vision, Halos, Light Sensitivity, Distance Vision Problem, Other Symptoms

4) By End User: Clinic, Hospital, Other End Users

Subsegments:

1) By Medication: Vitamin A Supplements, Retinoid Therapy, Beta-Carotene Supplements, Anti-Glaucoma Medications

2) By Surgery: Cataract Surgery, Retinal Surgery, Corneal Transplantation, LASIK Surgery

3) By Other Treatments: Light Therapy, Gene Therapy, Low Vision Aids And Assistive Devices, Nutritional Therapy

What Is The Driver Of The Night Blindness Treatment Market?

The increasing prevalence of cataracts is expected to propel the growth of the night blindness treatment market going forward. Cataracts refer to a condition where the eye's lens becomes cloudy, leading to impaired vision. The increased exposure to ultraviolet (UV) light from the sun, smoking, and poor diet contribute to the development of cataracts. Cataracts reduce the eye's ability to distinguish between different shades of light and dark, which is crucial for night vision. This decreased contrast sensitivity makes navigating and recognizing objects in low-light environments harder. For instance, in May 2024, according to the Office for Health Improvement & Disparities, a UK-based government department, hospital admissions for cataract surgery in England rose to more than 516,000 in the financial year ending 2023 equivalent to 4,679 per 100,000 people marking a significant increase from the prior year’s rate of 3,803 per 100,000. Therefore, the increasing prevalence of cataracts is driving the night blindness treatment industry.

Key Players In The Global Night Blindness Treatment Market

Major companies operating in the night blindness treatment market are Johnson & Johnson Private Limited, Bayer AG, Abbott Laboratories, Novartis AG, Regeneron Pharmaceuticals Inc, Bausch Health Companies Inc, Cipla Inc, Nature’s Way, Garden of Life, Apellis Pharmaceuticals Inc, Solgar, Acucela Inc, Swanson Health Products, Astellas Pharma Inc, F. Hoffmann-La Roche Ltd, Applied Genetic Technologies Corp, MeiraGTx Holdings plc, GenSight Biologics, Santen Pharmaceutical Co Ltd, Alimera Sciences Inc, Opthea Limited, Oxurion NV, EyePoint Pharmaceuticals Inc, Ocuphire Pharma Inc.

Global Night Blindness Treatment Market Trends and Insights

Major companies operating in the night blindness treatment market are developing innovative genetic therapies to address the underlying genetic mutations responsible for enhancing treatment efficacy for improved patient outcomes. Genetic therapies help in treating night blindness by targeting and repairing specific genetic mutations that affect retinal function, potentially restoring vision in individuals with inherited retinal disorders such as retinitis pigmentosa. For instance, in August 2023, HuidaGene Therapeutics., a US-based clinical-stage biotechnology company, introduced HG004, a gene therapy designed to treat inherited retinal diseases such as Leber's congenital amaurosis. This therapy has shown superiority over existing treatments in preclinical studies, aiming to restore retinal function and alleviate night blindness and other conditions associated with RPE65-induced impairments.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Night Blindness Treatment Market?

In October 2025, AviadoBio Ltd., a UK-based developer of targeted gene therapies for neurodegenerative and ocular conditions, entered into an exclusive option-license agreement with UgeneX Therapeutics to advance and potentially commercialize UGX-202, an optogenetics-based gene therapy designed to restore vision in patients with retinitis pigmentosa and other inherited retinal diseases. With this agreement, AviadoBio aims to expand its next-generation ocular gene therapy portfolio by leveraging UgeneX’s optimized AAV-based optogenetic platform to address profound photoreceptor loss and associated night blindness. UgeneX Therapeutics is a China-based biotechnology company specializing in gene therapy innovations for ophthalmic diseases, supported by a proprietary platform and a growing pipeline of retinal gene therapy candidates.

Regional Outlook

North America was the largest region in the night blindness treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Night Blindness Treatment Market?

The night blindness treatment market consists of revenues earned by entities by providing services such as diagnostic services, medical management and consultation, surgical interventions, and genetic counseling and testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The night blindness treatment market also includes sales of night vision goggles, retinal implants and prosthetics, electroretinography (ERG) systems, vitamin A supplements, and intraocular injections. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Night Blindness Treatment Market Report 2026?

The night blindness treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the night blindness treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Night Blindness Treatment Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $4.46 billion
Revenue Forecast In 2035 $5.66 billion
Growth Rate CAGR of 6.3% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Treatment, Diagnosis, Symptom, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Johnson & Johnson Private Limited, Bayer AG, Abbott Laboratories, Novartis AG, Regeneron Pharmaceuticals Inc, Bausch Health Companies Inc, Cipla Inc, Nature’s Way, Garden of Life, Apellis Pharmaceuticals Inc, Solgar, Acucela Inc, Swanson Health Products, Astellas Pharma Inc, F. Hoffmann-La Roche Ltd, Applied Genetic Technologies Corp, MeiraGTx Holdings plc, GenSight Biologics, Santen Pharmaceutical Co Ltd, Alimera Sciences Inc, Opthea Limited, Oxurion NV, EyePoint Pharmaceuticals Inc, Ocuphire Pharma Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Night Blindness Treatment Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Night Blindness Treatment Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Night Blindness Treatment Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Night Blindness Treatment Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Rising Prevalence Of Vitamin A Deficiency

4.2.2 Increasing Adoption Of Early Diagnosis Techniques

4.2.3 Growth In Minimally Invasive Eye Surgeries

4.2.4 Expanding Use Of Nutritional And Preventive Therapies

4.2.5 Improved Access To Vision Care In Emerging Economies

5. Night Blindness Treatment Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Ophthalmology Centers

5.4 Specialty Eye Care Centers

5.5 Ambulatory Surgical Centers

6. Night Blindness Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Night Blindness Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Night Blindness Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Night Blindness Treatment Market Size, Comparisons And Growth Rate Analysis

7.3. Global Night Blindness Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Night Blindness Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Night Blindness Treatment Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Night Blindness Treatment Market Segmentation

9.1. Global Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Medication, Surgery, Other Treatments

9.2. Global Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Blood Tests, Color Vision Testing, Pupil Light Reflex, Refraction, Retinal Exam, Electroretinogram (ERG), Other Diagnoses

9.3. Global Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Eye Pain, Cloudy Vision, Halos, Light Sensitivity, Distance Vision Problem, Other Symptoms

9.4. Global Night Blindness Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Clinic, Hospital, Other End Users

9.5. Global Night Blindness Treatment Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Vitamin A Supplements, Retinoid Therapy, Beta-Carotene Supplements, Anti-Glaucoma Medications

9.6. Global Night Blindness Treatment Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cataract Surgery, Retinal Surgery, Corneal Transplantation, LASIK Surgery

9.7. Global Night Blindness Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Light Therapy, Gene Therapy, Low Vision Aids And Assistive Devices, Nutritional Therapy

10. Night Blindness Treatment Market Regional And Country Analysis

10.1. Global Night Blindness Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Night Blindness Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Night Blindness Treatment Market

11.1. Asia-Pacific Night Blindness Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Night Blindness Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Night Blindness Treatment Market

12.1. China Night Blindness Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Night Blindness Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Night Blindness Treatment Market

13.1. India Night Blindness Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Night Blindness Treatment Market

14.1. Japan Night Blindness Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Night Blindness Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Night Blindness Treatment Market

15.1. Australia Night Blindness Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Night Blindness Treatment Market

16.1. Indonesia Night Blindness Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Night Blindness Treatment Market

17.1. South Korea Night Blindness Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Night Blindness Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Night Blindness Treatment Market

18.1. Taiwan Night Blindness Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Night Blindness Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Night Blindness Treatment Market

19.1. South East Asia Night Blindness Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Night Blindness Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Night Blindness Treatment Market

20.1. Western Europe Night Blindness Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Night Blindness Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Night Blindness Treatment Market

21.1. UK Night Blindness Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Night Blindness Treatment Market

22.1. Germany Night Blindness Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Night Blindness Treatment Market

23.1. France Night Blindness Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Night Blindness Treatment Market

24.1. Italy Night Blindness Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Night Blindness Treatment Market

25.1. Spain Night Blindness Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Night Blindness Treatment Market

26.1. Eastern Europe Night Blindness Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Night Blindness Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Night Blindness Treatment Market

27.1. Russia Night Blindness Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Night Blindness Treatment Market

28.1. North America Night Blindness Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Night Blindness Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Night Blindness Treatment Market

29.1. USA Night Blindness Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Night Blindness Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Night Blindness Treatment Market

30.1. Canada Night Blindness Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Night Blindness Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Night Blindness Treatment Market

31.1. South America Night Blindness Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Night Blindness Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Night Blindness Treatment Market

32.1. Brazil Night Blindness Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Night Blindness Treatment Market

33.1. Middle East Night Blindness Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Night Blindness Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Night Blindness Treatment Market

34.1. Africa Night Blindness Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Night Blindness Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Night Blindness Treatment Market Regulatory and Investment Landscape

36. Night Blindness Treatment Market Competitive Landscape And Company Profiles

36.1. Night Blindness Treatment Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Night Blindness Treatment Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Night Blindness Treatment Market Company Profiles

36.3.1. Johnson & Johnson Private Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Regeneron Pharmaceuticals Inc Overview, Products and Services, Strategy and Financial Analysis

37. Night Blindness Treatment Market Other Major And Innovative Companies

Bausch Health Companies Inc, Cipla Inc, Nature’s Way, Garden of Life, Apellis Pharmaceuticals Inc, Solgar, Acucela Inc, Swanson Health Products, Astellas Pharma Inc, F. Hoffmann-La Roche Ltd, Applied Genetic Technologies Corp, MeiraGTx Holdings plc, GenSight Biologics, Santen Pharmaceutical Co Ltd, Alimera Sciences Inc

38. Global Night Blindness Treatment Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Night Blindness Treatment Market

40. Night Blindness Treatment Market High Potential Countries, Segments and Strategies

40.1 Night Blindness Treatment Market In 2030 - Countries Offering Most New Opportunities

40.2 Night Blindness Treatment Market In 2030 - Segments Offering Most New Opportunities

40.3 Night Blindness Treatment Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Night Blindness Treatment Market, Overview Of Key Products - Product Examples
  • Table 2: Global Night Blindness Treatment Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Night Blindness Treatment Market, Supply Chain Analysis
  • Table 4: Global Night Blindness Treatment Market, Major Raw Material Providers
  • Table 5: Global Night Blindness Treatment Market, Major Resource Providers
  • Table 6: Global Night Blindness Treatment Market, Major Manufacturers (Suppliers)
  • Table 7: Global Night Blindness Treatment Market, Major Distributors And Channel Partners
  • Table 8: Global Night Blindness Treatment Market, Key Technologies & Future Trends
  • Table 9: Global Night Blindness Treatment Market, Major Trends
  • Table 10: Global Night Blindness Treatment Market, Major End Users
  • Table 11: Global Night Blindness Treatment Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Night Blindness Treatment Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Night Blindness Treatment Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Night Blindness Treatment Market - TAM, US$ Billion, 2025
  • Table 15: Global Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Night Blindness Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Night Blindness Treatment Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Night Blindness Treatment Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Night Blindness Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Night Blindness Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Night Blindness Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Global Night Blindness Treatment Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 97: Global Night Blindness Treatment Market - Company Scoring Matrix
  • Table 98: Johnson & Johnson Private Limited Financial Performance
  • Table 99: Bayer AG Financial Performance
  • Table 100: Abbott Laboratories Financial Performance
  • Table 101: Novartis AG Financial Performance
  • Table 102: Regeneron Pharmaceuticals Inc Financial Performance
  • Table 103: Global Night Blindness Treatment Market, Competitive Benchmarking (In USD Billions)
  • Table 104: Global Night Blindness Treatment Market, Competitive Dashboard
  • Table 105: Global Night Blindness Treatment Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 106: Global, Night Blindness Treatment Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Table 107: Global, Night Blindness Treatment Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030
  • Table 108: Global, Night Blindness Treatment Market Size Gain ($ Billion), Segmentation By Symptom, 2025 – 2030

List Of Figures

    Figure 1: Global Night Blindness Treatment Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Night Blindness Treatment Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Night Blindness Treatment Market, Supply Chain Analysis
  • Figure 4: Global Night Blindness Treatment Market, Major Raw Material Providers
  • Figure 5: Global Night Blindness Treatment Market, Major Resource Providers
  • Figure 6: Global Night Blindness Treatment Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Night Blindness Treatment Market, Major Distributors And Channel Partners
  • Figure 8: Global Night Blindness Treatment Market, Key Technologies & Future Trends
  • Figure 9: Global Night Blindness Treatment Market, Major Trends
  • Figure 10: Global Night Blindness Treatment Market, Major End Users
  • Figure 11: Global Night Blindness Treatment Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Night Blindness Treatment Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Night Blindness Treatment Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Night Blindness Treatment Market - TAM, US$ Billion, 2025
  • Figure 15: Global Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Night Blindness Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Night Blindness Treatment Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Night Blindness Treatment Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Night Blindness Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Night Blindness Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Night Blindness Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Night Blindness Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Night Blindness Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Night Blindness Treatment Market, Segmentation By Symptom, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Global Night Blindness Treatment Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 97: Global Night Blindness Treatment Market - Company Scoring Matrix
  • Figure 98: Johnson & Johnson Private Limited Financial Performance
  • Figure 99: Bayer AG Financial Performance
  • Figure 100: Abbott Laboratories Financial Performance
  • Figure 101: Novartis AG Financial Performance
  • Figure 102: Regeneron Pharmaceuticals Inc Financial Performance
  • Figure 103: Global Night Blindness Treatment Market, Competitive Benchmarking (In USD Billions)
  • Figure 104: Global Night Blindness Treatment Market, Competitive Dashboard
  • Figure 105: Global Night Blindness Treatment Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 106: Global, Night Blindness Treatment Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Figure 107: Global, Night Blindness Treatment Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030
  • Figure 108: Global, Night Blindness Treatment Market Size Gain ($ Billion), Segmentation By Symptom, 2025 – 2030

Next-Gen Primary Health Care Service : Market Forecast, Transformation, and Long-Term Trajectories

Read More About Next-Gen Primary Health Care Service : Market Forecast, Transformation, and Long-Term Trajectories

Progressive Ataxia And Weakness Disorders Growth Trajectory: Key Forecasts and Strategic Insights

Read More About Progressive Ataxia And Weakness Disorders Growth Trajectory: Key Forecasts and Strategic Insights

Prostate Cancer Nuclear Medicine Diagnostics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About Prostate Cancer Nuclear Medicine Diagnostics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Prostate Cancer Nuclear Medicine Diagnostics Market Landscape: Automated Parallel Capillary Electrophoresis Systems Transforming Protein Analysis In The Protein Chip Market

Read More About Emerging Trends Redefining the Prostate Cancer Nuclear Medicine Diagnostics Market Landscape: Automated Parallel Capillary Electrophoresis Systems Transforming Protein Analysis In The Protein Chip Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Night Blindness Treatment Market Report 2026 - Global Outlook – By Treatment (Medication, Surgery, Other Treatments), By Diagnosis (Blood Tests, Color Vision Testing, Pupil Light Reflex, Refraction, Retinal Exam, Electro...

Retinal Disorder Treatment Market Report 2026 - Global Outlook – By Type (Macular Degeneration, Diabetic Retinopathy, Other Types), By Dosage Form (Gels, Eye Solutions, Capsules And Tablets, Eye Drops, Ointments), By Dis...

Night Vision Devices Market Report 2026 - Global Outlook – By Device ( Goggles, Monocular And Binoculars, Camera, Glasses, Scopes, Other Devices), By Technology ( Thermal Imaging, Image Intensifier, Infrared Illumination...

Optic Nerve Disorders Treatment Market Report 2026 - Global Outlook – By Treatment Type (Steroidal Therapy, Immunomodulators therapy, Other Treatment Types), By Indication (Glaucoma, Optic Neuritis, Optic Neuropathy, Con...

Light Therapy Market Report 2026 - Global Outlook – By Product (Light Box, Floor And Desk Lamps, Handheld Devices For Skin Treatment, Light Visor, Light Therapy Lamps, Other Products), By Light Type (White Light, Blue Li...

Ocular Hypertension Treatment Market Report 2026 - Global Outlook – By Type (Intraocular Hypertension, Glaucoma), By Route Of Administration (Oral, Parenteral, Other Route Of Administrations), By Distribution Channel (Ho...

Ocular Inflammation Treatment Market Report 2026 - Global Outlook – By Treatment Type (Immunosuppressant, Antivirals, Corticosteroids, Monoclonal Antibodies, Antifungal, Cycloplegic), By Mode Of Operation (Injectables, O...

Automotive Night Vision System Market Report 2026 - Global Outlook – By Component Type ( Night Vision Camera, Sensor, Display Unit, Controlling Unit, Other Components), By Technology ( Far Infrared (FIR), Near-Infrared (...

Frequently Asked Questions

The Night Blindness Treatment market was valued at $4.2 billion in 2025, increased to $4.46 billion in 2026, and is projected to reach $5.66 billion by 2030.

The global Night Blindness Treatment market is expected to grow at a CAGR of 6.1% from 2026 to 2035 to reach $5.66 billion by 2035.

Some Key Players in the Night Blindness Treatment market Include, Johnson & Johnson Private Limited, Bayer AG, Abbott Laboratories, Novartis AG, Regeneron Pharmaceuticals Inc, Bausch Health Companies Inc, Cipla Inc, Nature’s Way, Garden of Life, Apellis Pharmaceuticals Inc, Solgar, Acucela Inc, Swanson Health Products, Astellas Pharma Inc, F. Hoffmann‑La Roche Ltd, Applied Genetic Technologies Corp, MeiraGTx Holdings plc, GenSight Biologics, Santen Pharmaceutical Co Ltd, Alimera Sciences Inc, Opthea Limited, Oxurion NV, EyePoint Pharmaceuticals Inc, Ocuphire Pharma Inc. .

Major trend in this market includes: Innovative Genetic Therapies Revolutionizing Night Blindness Treatment Market. For further insights on this market. request a sample here

North America was the largest region in the night blindness treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the night blindness treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us